Université de Paris, Centre de Recherche Cardiovasculaire de Paris, INSERM, Paris, France; Paris-Sudden Death Expertise Center, Paris, France; European Georges Pompidou Hospital, Cardiology Department, Paris, France.
Université de Paris, Centre de Recherche Cardiovasculaire de Paris, INSERM, Paris, France; Paris-Sudden Death Expertise Center, Paris, France; European Georges Pompidou Hospital, Cardiology Department, Paris, France.
Lancet Public Health. 2020 Aug;5(8):e437-e443. doi: 10.1016/S2468-2667(20)30117-1. Epub 2020 May 27.
Although mortality due to COVID-19 is, for the most part, robustly tracked, its indirect effect at the population level through lockdown, lifestyle changes, and reorganisation of health-care systems has not been evaluated. We aimed to assess the incidence and outcomes of out-of-hospital cardiac arrest (OHCA) in an urban region during the pandemic, compared with non-pandemic periods.
We did a population-based, observational study using data for non-traumatic OHCA (N=30 768), systematically collected since May 15, 2011, in Paris and its suburbs, France, using the Paris Fire Brigade database, together with in-hospital data. We evaluated OHCA incidence and outcomes over a 6-week period during the pandemic in adult inhabitants of the study area.
Comparing the 521 OHCAs of the pandemic period (March 16 to April 26, 2020) to the mean of the 3052 total of the same weeks in the non-pandemic period (weeks 12-17, 2012-19), the maximum weekly OHCA incidence increased from 13·42 (95% CI 12·77-14·07) to 26·64 (25·72-27·53) per million inhabitants (p<0·0001), before returning to normal in the final weeks of the pandemic period. Although patient demographics did not change substantially during the pandemic compared with the non-pandemic period (mean age 69·7 years [SD 17] vs 68·5 [18], 334 males [64·4%] vs 1826 [59·9%]), there was a higher rate of OHCA at home (460 [90·2%] vs 2336 [76·8%]; p<0·0001), less bystander cardiopulmonary resuscitation (239 [47·8%] vs 1165 [63·9%]; p<0·0001) and shockable rhythm (46 [9·2%] vs 472 [19·1%]; p<0·0001), and longer delays to intervention (median 10·4 min [IQR 8·4-13·8] vs 9·4 min [7·9-12·6]; p<0·0001). The proportion of patients who had an OHCA and were admitted alive decreased from 22·8% to 12·8% (p<0·0001) in the pandemic period. After adjustment for potential confounders, the pandemic period remained significantly associated with lower survival rate at hospital admission (odds ratio 0·36, 95% CI 0·24-0·52; p<0·0001). COVID-19 infection, confirmed or suspected, accounted for approximately a third of the increase in OHCA incidence during the pandemic.
A transient two-times increase in OHCA incidence, coupled with a reduction in survival, was observed during the specified time period of the pandemic when compared with the equivalent time period in previous years with no pandemic. Although this result might be partly related to COVID-19 infections, indirect effects associated with lockdown and adjustment of health-care services to the pandemic are probable. Therefore, these factors should be taken into account when considering mortality data and public health strategies.
The French National Institute of Health and Medical Research (INSERM).
虽然 COVID-19 导致的死亡率在很大程度上得到了准确的追踪,但它在人群层面上通过封锁、生活方式改变和医疗系统重组产生的间接影响尚未得到评估。我们旨在评估大流行期间巴黎及其郊区(法国)非创伤性院外心脏骤停(OHCA)的发病率和结局,与非大流行时期相比。
我们进行了一项基于人群的观察性研究,使用了自 2011 年 5 月 15 日以来在巴黎消防局数据库中系统收集的非创伤性 OHCA(N=30768)的数据,以及院内数据。我们评估了大流行期间研究区域成年居民在 6 周内的 OHCA 发病率和结局。
与非大流行时期(2012-19 年第 12-17 周)相同的 3052 例 OHCA 总数的平均值相比,大流行期间(2020 年 3 月 16 日至 4 月 26 日)的 521 例 OHCA 的最高每周 OHCA 发病率从 13.42(95%CI 12.77-14.07)增加到 26.64(25.72-27.53)每百万居民(p<0.0001),然后在大流行期间的最后几周恢复正常。与非大流行时期相比,大流行期间患者的人口统计学特征没有发生实质性变化(平均年龄 69.7 岁[SD 17]与 68.5 [18],334 名男性[64.4%]与 1826 名[59.9%]),但在家中发生 OHCA 的比例更高(460 [90.2%]与 2336 [76.8%];p<0.0001),旁观者心肺复苏(CPR)较少(239 [47.8%]与 1165 [63.9%];p<0.0001),可电击节律(46 [9.2%]与 472 [19.1%];p<0.0001),干预延迟时间更长(中位数 10.4 分钟[IQR 8.4-13.8]与 9.4 分钟[7.9-12.6];p<0.0001)。在大流行期间,发生 OHCA 并存活入院的患者比例从 22.8%降至 12.8%(p<0.0001)。在校正潜在混杂因素后,大流行期间与入院生存率显著降低相关(优势比 0.36,95%CI 0.24-0.52;p<0.0001)。COVID-19 感染,确诊或疑似,占大流行期间 OHCA 发病率增加的近三分之一。
与前几年没有大流行的同期相比,大流行期间特定时期 OHCA 的发病率增加了两倍,同时生存率降低。尽管这一结果可能部分与 COVID-19 感染有关,但与封锁和医疗服务调整以应对大流行相关的间接影响可能是。因此,在考虑死亡率数据和公共卫生策略时,应考虑这些因素。
法国国家健康与医学研究所(INSERM)。